Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of AM-101 in the Treatment of Acute Peripheral Tinnitus 3

NCT02040194 is registered in ClinicalTrials.gov with Auris Medical AG as lead sponsor.

NCT NCT02040194
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02040194 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of AM-101 in the Treatment of Acute Peripheral Tinnitus 3
Lead sponsor
Auris Medical AG
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2014
Completion date
December 28, 2017
Enrollment
893 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tinnitus